focus -WSS

focus

author：knowledge 2025-09-03 03:46:44 - browse：99

John Crowley pictured with his daughter Megan Crowley — health policy news from STAT — John Crowley pictured with his daughter Megan. Crowley family

WASHINGTON — The Biotechnology Innovation Organization has chosen longtime biotech executive and rare disease advocate John Crowley as its new CEO, the organization announced Tuesday.

Crowley came to biotech when his children were diagnosed with a rare genetic neuromuscular disease. He started working at Bristol Myers Squibb, and started Novazyme, which was eventually successful in creating an enzyme replacement therapy for Pompe disease. He later started and worked for several different biotech companies, most recently with Amicus Therapeutics, which had a drug approved to treat the disease in September.

The trade association’s board chair, Ted Love, served on the board of the company.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

WSS

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

Does good food count as health care? Study aims to find out

As pharma fights Medicare drug negotiation, hospitals, docs silent

World's first CRISPR

Readout LOUD podcast: A CRISPR milestone, biotech mixology

Diversity in medical illustrations gets boost from Chidiebere Ibe

hotspot

focus

knowledge

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

A daunting task: navigating dual Medicare, Medicaid eligibility

After affirmative action ruling, medical educators look to 'holistic review'

Why medical students are struggling with mental health

Bright Health sells Medicare Advantage business to Molina

Why medical students are struggling with mental health

Activists slam private health insurers over coverage restrictions

CDC advisory panel says seniors 'may' get RSV vaccine

Apple is now the first public company to be valued at $3 trillion

CRISPR pioneers react to Casgevy, first gene

focus

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

How Long Island became the ‘eugenics capital of the world’

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

Wegovy, Zepbound and weight loss drugs that preserve muscle

Why more medical students aren't specializing in primary care

Appeals court upholds limits to abortion pill

focus

hotspot

hotspot

focus